Endometriosis is often described in terms of lesions and hormones, and for good reason—that’s where treatment starts. But many women live a version of the disease that the standard framing doesn’t fully capture: they’ve had the surgery, they’ve tried the hormonal therapies, and the pain is still there. When that happens, it’s easy to feel dismissed, or to wonder if the pain is somehow imagined. It isn’t. There’s a real, well-described reason pelvic pain can outlast its original source, and it’s the reason ketamine enters the conversation.
When the Pain Outlives the Disease
Endometriosis pain doesn’t only come from the lesions themselves. Years of pain signaling change the nervous system that carries and processes those signals.
Prolonged input from endometriosis drives up NMDA-receptor activity and gradually remodels the central sensory pathways in the spinal cord and brain. That remodeling produces central sensitization: the pain-processing system becomes hyperexcitable, amplifying signals and, eventually, generating pain on its own. Once that has taken hold, removing the lesions and controlling hormones may not switch the pain off, because the problem has partly moved from the pelvis into the nervous system.
This is the same mechanism we describe in ketamine and central sensitization, and it’s the thread that links stubborn endometriosis pain to conditions like fibromyalgia and neuropathic pain generally. Recognizing it isn’t a way of saying the pain is “in your head”—it’s a precise description of a physical change in how the pain system behaves.
Prolonged nociceptive input in endometriosis upregulates NMDA receptors and remodels central pain pathways, producing central sensitization—pain that can persist even after lesions are removed and hormones are controlled. — Synthesized from research on pain mechanisms in endometriosis
Where Ketamine Fits
Central sensitization depends heavily on the NMDA receptor, which amplifies pain signaling when pain circuits fire over and over—the “wind-up” that pain scientists describe. Ketamine is an NMDA-receptor antagonist: it turns that receptor down, interrupting the amplification and calming the hyperexcitability that sensitized pelvic pain runs on. Researchers describe NMDA-receptor antagonists like esketamine as able to halt the excessive barrage of pain signals and help reverse chronic sensitization.
That’s a fundamentally different action from most pelvic pain treatments, which target hormones or inflammation. It’s why ketamine has a rationale specifically for the sensitized pain that other approaches leave behind. Our explainer on how ketamine works covers the glutamate and NMDA side in more detail.
What the Research Actually Shows
Here we’d rather give you the honest, early-stage picture than oversell it.
The most directly relevant finding comes from a small retrospective cohort of patients with chronic endometriosis-associated pain that had resisted current treatments. Esketamine infusion therapy had a positive effect on pain in about 65% of them—a meaningful signal in a group that had already run out of standard options. Encouragingly, researchers considered the results strong enough to justify a double-blind randomized controlled trial, which is now underway to test the approach more rigorously.
There’s a second, better-established use worth noting: ketamine is used around the time of endometriosis surgery to reduce postoperative pain and help prevent opioid tolerance. That’s a surgical decision made by the operative team, but it reflects the same underlying logic—that blunting NMDA-driven sensitization can change how pain behaves.
The honest caveat is that this is an emerging area built on small studies and case reports, not a proven standard of care. Ketamine for endometriosis pain is a promising, mechanistically sensible option in a genuinely hard-to-treat condition—which is a different and more useful claim than saying it’s established. We’d rather you hear that clearly.
What Ketamine Doesn’t Do
This part matters. Ketamine does not treat endometriosis. It doesn’t shrink lesions, address the hormonal drivers, or replace surgery or gynecologic care. Those remain the foundation, managed by your gynecologist or endometriosis specialist. Ketamine is aimed narrowly at one thing—the centrally sensitized pain that can persist despite good disease-directed treatment—and it belongs inside a coordinated plan, not as a substitute for one. When someone is considering it, we coordinate with the clinicians managing the endometriosis itself, in the spirit of what to tell your PCP about ketamine.
How We’d Think About It
A careful evaluation for chronic pelvic pain looks at:
- The character and history of your pain—whether it has taken on a widespread, sensitized quality that persists between flares and after treatment, versus tracking closely with disease activity.
- What disease-directed care you’ve had—surgery, hormonal therapy—and who is managing it, so ketamine complements rather than duplicates that work.
- Your full medication list, since women with chronic pelvic pain are often on several medications and interactions matter.
- Blood pressure and cardiovascular status, because ketamine can transiently raise both during an infusion.
- Realistic goals—usually turning down a sensitized pain system and creating room for other therapies, and sometimes reducing opioid reliance, rather than expecting a single course to erase the pain.
If ketamine fits, most protocols begin with an initial series of monitored infusions. The experience itself matters, especially for someone worn down by years of pain and of not being believed. Our sessions are unhurried and closely attended—Marla stays present throughout—and our therapy dogs, Walter White and Wilma, are part of the calm of the room. Candidacy and monitoring are covered in is ketamine therapy safe, and our broader approach to nerve-driven pain lives on our chronic pain page. If your pain also tracks with your cycle, our piece on ketamine for PMDD may be relevant too.
An Honest Bottom Line
Endometriosis pain that survives surgery and hormones isn’t a sign that you’re imagining things—it’s often a sign that the pain has become centrally sensitized, and that’s precisely where ketamine’s mechanism has something to offer. The evidence is early but genuinely promising, with a randomized trial now testing it properly. Ketamine won’t treat the disease, and it isn’t a fit for everyone. But for the sensitized pelvic pain that keeps outliving its cause, we’d be glad to look at your situation honestly and tell you whether it belongs in your plan.